| Brand Name | ONX AORTIC CONFORM EXT 23 |
| Common Device Name | HEART-VALVE, MECHANICAL |
| Manufacturer (Section D) |
| CRYOLIFE, INC. ¿ AUSTIN |
| 1300 e. anderson ln., bldg. b |
| austin TX 78752 |
|
| MDR Report Key | 11895855 |
| Report Number | 1649833-2021-00017 |
| Device Sequence Number | 1413724 |
| Product Code |
LWQ
|
| UDI-Device Identifier | 00851788001464 |
| UDI-Public | 00851788001464 |
| Combination Product (Y/N) | N |
| Initial Reporter State | OR |
| Initial Reporter Country | US |
| PMA/510(K) Number | P000037 |
| Number of Events Summarized | 1 |
| Summary Report (Y/N) | N |
| Reporter Type |
Manufacturer
|
| Report Source |
company representative,health |
| Initial Reporter Occupation |
Other
|
| Type of Report
| Initial,Followup |
| Report Date (Section B) |
06/23/2021 |
| 1 Device was Involved in the Event |
|
| 1 Patient was Involved in the Event |
|
| Is this an Adverse Event Report? |
Yes
|
| Is this a Product Problem Report? |
No
|
| Operator of Device |
No Information
|
| Device Expiration Date | 08/16/2022 |
| Device Model Number | ONXACE-23 |
| Was Device Available for Evaluation? |
No
|
| Distributor Facility Aware Date | 05/06/2021 |
| Initial Date Received by Manufacturer | 05/06/2021 |
| Supplement Date Received by Manufacturer | 05/06/2021
|
| Initial Report FDA Received Date | 05/27/2021 |
| Supplement Report FDA Received Date | 06/23/2021
|
| Patient Sequence Number | 1 |
| Outcome Attributed to Adverse Event |
Required Intervention;
|
| Patient Age | 46 YR |
|
|